Additionally, DPP4 inhibitors may protect against the progression of cognitive disorders in diabetic individuals by increasing neurotrophin levels, such as BDNF, NGF, and NT-4 [57], promoting neuronal growth, survival, and synaptic plasticity. This evidence concerns the gene DPP4 and cognitive disorder.